Provided by Tiger Fintech (Singapore) Pte. Ltd.

Skye Bioscience Inc.

1.44
-0.1450-9.18%
Post-market: 1.43-0.0048-0.33%19:49 EDT
Volume:587.64K
Turnover:880.62K
Market Cap:44.45M
PE:-1.97
High:1.65
Open:1.58
Low:1.41
Close:1.58
Loading ...
Sep 15, 2021

Major Issues Report

8-K - Current report
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 26, 2021

Major Issues Report

8-K - Current report
Jul 22, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2021

Major Issues Report

8-K - Current report
Jan 19, 2021

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 28, 2020

Major Issues Report

8-K - Current report
Aug 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 13, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 07, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 05, 2020

Major Issues Report

8-K - Current report